STERIS plc (NYSE:STE) Holdings Lowered by Magnetar Financial LLC

Magnetar Financial LLC lessened its stake in STERIS plc (NYSE:STE - Free Report) by 55.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,381 shares of the medical equipment provider's stock after selling 11,827 shares during the quarter. Magnetar Financial LLC's holdings in STERIS were worth $1,928,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Principal Financial Group Inc. raised its stake in STERIS by 9.5% during the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock valued at $270,230,000 after buying an additional 96,336 shares in the last quarter. Pathstone Holdings LLC increased its holdings in shares of STERIS by 0.8% in the 3rd quarter. Pathstone Holdings LLC now owns 35,875 shares of the medical equipment provider's stock valued at $8,701,000 after acquiring an additional 283 shares during the last quarter. Caprock Group LLC bought a new position in STERIS during the third quarter worth $839,000. PNC Financial Services Group Inc. boosted its holdings in STERIS by 0.7% in the third quarter. PNC Financial Services Group Inc. now owns 37,931 shares of the medical equipment provider's stock worth $9,200,000 after purchasing an additional 279 shares during the period. Finally, Citizens Financial Group Inc. RI acquired a new position in STERIS in the third quarter worth $223,000. Institutional investors own 94.69% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on STE. Stephens reissued an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, JMP Securities restated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, STERIS has a consensus rating of "Moderate Buy" and a consensus target price of $258.75.

Remove Ads

STERIS Stock Performance

Shares of STERIS stock traded down $1.44 during trading on Tuesday, hitting $221.57. 550,996 shares of the stock were exchanged, compared to its average volume of 504,069. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock's fifty day moving average is $221.34 and its 200 day moving average is $221.73. The stock has a market cap of $21.77 billion, a PE ratio of 47.04 and a beta of 0.92.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, sell-side analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS's dividend payout ratio (DPR) is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.